fbpx

Latest News

From Overlooked to Understood: Why Research Must Reflect Real Lives

Every November, the U.S. Pain Foundation brings our community together to spotlight something powerful: knowledge.  We call it KNOWvember—a month-long campaign amplifying a theme that matters deeply to the pain community. This year, we’re focusing on an area that has...

Kelly Amspacher

Experiment Today, Hope Tomorrow: Engaging in Migraine Studies

Reggie Barnes

When Relief Requires Research: From Patient to Advocate

Monica Thomas

Asking Questions, Finding Hope: The Impact of Avid Study Participation

SUBMITTED COMMENTS and LETTERS

PRESS
RELEASES

 

MEDIA
COVERAGE

 

REMEDY
BLOG

 

Read U.S. Pain’s letter to the FDA

Read U.S. Pain’s letter to the FDA

U.S. Pain Foundation was among several hundred organizations and individuals to weigh in on a recent Food and Drug Administration (FDA) comment period. Specifically, the FDA asked for the public's views on two main issues: What criteria the FDA...

How should the FDA evaluate new medications for pain?

How should the FDA evaluate new medications for pain?

We wanted to make you aware of an opportunity to submit public comments to the Food and Drug Administration (FDA). Specifically, the FDA would like the public's views on two main issues: What criteria the FDA should use to evaluate new opioids to...

Pain Warrior of the Month: LaSheila Yates

Pain Warrior of the Month: LaSheila Yates

Name: LaSheila Yates Location: Cedar Rapids, IA Age: 38 Pain warrior role: U.S. Pain advocate since 2019 Health conditions: ulcerative colitis, pelvic floor dysfunction, neuropathic pain, gastroesophageal reflux disease (GERD), pouchitis, cuffitis,...

Archives